Lehr Martin A.
SEC insider (Form 3/4/5 filer). CIK 0001861989. Chief Executive Officer at Context Therapeutics Inc. (CNTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2026. Located in PHILADELPHIA, PA.
Companies Lehr Martin A. has filed insider reports for
- Context Therapeutics Inc. (CNTX): Director, Officer, Chief Executive Officer
Lehr Martin A.
CIK: 0001861989
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNTX
Context Therapeutics Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 19, 2026CNTX
Context Therapeutics Inc.
AwardDirectStock Option (right to buy)
815K shares- - Jun 9, 2025CNTX
Context Therapeutics Inc.
PurchaseIndirect100K shares at avg. $0.70$70K - Feb 13, 2025CNTX
Context Therapeutics Inc.
AwardDirectStock Option (right to buy)
802.7K shares-
1-3 of 3 transactions